These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 21956479)

  • 1. Proteomic strategy for detection of circulating tumor cell surface antigens.
    Mints M; Souchelnytskyi S
    Exp Oncol; 2011 Sep; 33(3):193-5. PubMed ID: 21956479
    [No Abstract]   [Full Text] [Related]  

  • 2. [Flow cytometric cell analysis by surface antigen according to CD grouping].
    Tsuruda K; Hamasaki N; Matsuno T; Moriuchi T; Atogami S; Kamihira S
    Nihon Rinsho; 2010 Jun; 68 Suppl 6():847-54. PubMed ID: 20942203
    [No Abstract]   [Full Text] [Related]  

  • 3. Evaluation of circulating tumour cells expressing CD44 variants in the blood of gastric cancer patients by flow cytometry.
    Pituch-Noworolska A; Wieckiewicz J; Krzeszowiak A; Stachura J; Ruggiero I; Gawlicka M; Szczepanik A; Karcz D; Popiela T; Zembala M
    Anticancer Res; 1998; 18(5B):3747-52. PubMed ID: 9854488
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The clinical significance of circulating tumor cells in the peripheral blood.
    Elshimali YI; Grody WW
    Diagn Mol Pathol; 2006 Dec; 15(4):187-94. PubMed ID: 17122646
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Presto change-o: the epithelial-mesenchymal transition.
    Cassiday L
    J Proteome Res; 2009 Jan; 8(1):2. PubMed ID: 19118446
    [No Abstract]   [Full Text] [Related]  

  • 6. Clinical proteomics: liquid chromatography-mass spectrometry purification systems.
    Henry M; Meleady P
    Methods Mol Biol; 2011; 681():473-83. PubMed ID: 20978984
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Changing levels of circulating tumor cells in monitoring chemotherapy response in patients with metastatic breast cancer.
    Hartkopf AD; Wagner P; Wallwiener D; Fehm T; Rothmund R
    Anticancer Res; 2011 Mar; 31(3):979-84. PubMed ID: 21498725
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mucosal vaccination with phage-displayed tumour antigens identified through proteomics-based strategy inhibits the growth and metastasis of 4T1 breast adenocarcinoma.
    Shadidi M; Sørensen D; Dybwad A; Furset G; Sioud M
    Int J Oncol; 2008 Jan; 32(1):241-7. PubMed ID: 18097564
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biomarker discovery in low-grade breast cancer using isobaric stable isotope tags and two-dimensional liquid chromatography-tandem mass spectrometry (iTRAQ-2DLC-MS/MS) based quantitative proteomic analysis.
    Bouchal P; Roumeliotis T; Hrstka R; Nenutil R; Vojtesek B; Garbis SD
    J Proteome Res; 2009 Jan; 8(1):362-73. PubMed ID: 19053527
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proteomics in tumor progression and metastasis.
    Everley PA; Zetter BR
    Ann N Y Acad Sci; 2005 Nov; 1059():1-10. PubMed ID: 16382037
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The use of nested RT-PCR of prostate-specific membrane antigen in blood cells: implications for the detection of haematogenous neoplastic cells in patients with prostate adenocarcinoma.
    Lucotte G; Mercier G; Burckel A
    Mol Cell Probes; 1998 Dec; 12(6):421-5. PubMed ID: 9843660
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis by fluorescence microscopy and flow cytometry of monoclonal antibodies produced against cell surface antigens.
    Bolaños B; Bodón Q; Jiménez T; García-Mayol D; Lavergne JA; Díaz AM
    P R Health Sci J; 1988 Apr; 7(1):35-8. PubMed ID: 3375422
    [TBL] [Abstract][Full Text] [Related]  

  • 13. T-cell activation-associated antigen expression by neoplastic T-cells.
    Chadburn A; Inghirami G; Knowles DM
    Hematol Pathol; 1992; 6(3):131-41. PubMed ID: 1429341
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficient isolation and quantitative proteomic analysis of cancer cell plasma membrane proteins for identification of metastasis-associated cell surface markers.
    Lund R; Leth-Larsen R; Jensen ON; Ditzel HJ
    J Proteome Res; 2009 Jun; 8(6):3078-90. PubMed ID: 19341246
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum proteomics study of the squamous cell carcinoma antigen 1 in tongue cancer.
    Huang X; Wei Y; Li L; Wen Y; Yang J; Liu B; Song X; Zhao J
    Oral Oncol; 2006 Jan; 42(1):26-31. PubMed ID: 16143561
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical proteomics and mass spectrometry profiling for cancer detection.
    Solassol J; Jacot W; Lhermitte L; Boulle N; Maudelonde T; Mangé A
    Expert Rev Proteomics; 2006 Jun; 3(3):311-20. PubMed ID: 16771703
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification and validation of cell surface antigens for antibody targeting in oncology.
    Carter P; Smith L; Ryan M
    Endocr Relat Cancer; 2004 Dec; 11(4):659-87. PubMed ID: 15613445
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discovery of human antibodies to cell surface antigens by capture lift screening of phage-expressed antibody libraries.
    Watkins JD; Beuerlein G; Wu H; McFadden PR; Pancook JD; Huse WD
    Anal Biochem; 1998 Feb; 256(2):169-77. PubMed ID: 9473274
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Autoantibody profiling for cancer detection.
    Qiu J; Hanash S
    Clin Lab Med; 2009 Mar; 29(1):31-46. PubMed ID: 19389549
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multi-dimensional capillary electrophoresis and chromatography for proteomic analysis.
    Gao M; Zhang X
    Methods Mol Biol; 2008; 384():783-801. PubMed ID: 18392595
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.